Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Robins

Showing results (211-220 of 221) with videos related to

Pageof 23
Sort By:
Emergency Radiology|June 13, 2025
Promising initial evaluation: the Shock Thyroid Imaging Score (STIS) could predict mortality in hemodynamically unstable trauma patientsMatthew C Mueller, Jacques du Plessis, Abdelazim M E Mohammed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Emergency Radiology|March 17, 2025
Overnight emergency radiologist coverage model with preserved resident autonomy: impact on report turnaround times and resident experienceRawan Abu Mughli, Deyvison T Baia Medeiros, Róisín MacDermott, et al.
Journal of Translational Medicine|March 21, 2009
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCsMark M Aloysius, Alastair J Mc Kechnie, Richard A Robins, et al.
Cancer Research|April 5, 2000
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genesS A Ali, C S McLean, M E Boursnell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
The New England Journal of Medicine|June 10, 2024
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver FibrosisRohit Loomba, Mark L Hartman, Eric J Lawitz, et al.
Cell Metabolism|January 11, 2023
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonistOlivier Benichou, Tamer Coskun, Malgorzata D Gonciarz, et al.
Acta Physiologica (Oxford, England)|February 24, 2015
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cellsL Jean-Gilles, M Braitch, M L Latif, et al.
Andrology|March 13, 2018
Development of a selective androgen receptor modulator for transdermal use in hypogonadal patientsV Krishnan, N J Patel, J G Mackrell, et al.
Pageof 23

Showing results (211-220 of 221) with videos related to

Sort By:
Pageof 23
Emergency Radiology|June 13, 2025
Promising initial evaluation: the Shock Thyroid Imaging Score (STIS) could predict mortality in hemodynamically unstable trauma patientsMatthew C Mueller, Jacques du Plessis, Abdelazim M E Mohammed, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 9, 2014
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral densityRobert R Recker, Charles T Benson, Toshio Matsumoto, et al.
Emergency Radiology|March 17, 2025
Overnight emergency radiologist coverage model with preserved resident autonomy: impact on report turnaround times and resident experienceRawan Abu Mughli, Deyvison T Baia Medeiros, Róisín MacDermott, et al.
Journal of Translational Medicine|March 21, 2009
Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCsMark M Aloysius, Alastair J Mc Kechnie, Richard A Robins, et al.
Cancer Research|April 5, 2000
Preclinical evaluation of "whole" cell vaccines for prophylaxis and therapy using a disabled infectious single cycle-herpes simplex virus vector to transduce cytokine genesS A Ali, C S McLean, M E Boursnell, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 25, 2015
The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral DensityChristopher P Recknor, Robert R Recker, Charles T Benson, et al.
The New England Journal of Medicine|June 10, 2024
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver FibrosisRohit Loomba, Mark L Hartman, Eric J Lawitz, et al.
Cell Metabolism|January 11, 2023
Discovery, development, and clinical proof of mechanism of LY3463251, a long-acting GDF15 receptor agonistOlivier Benichou, Tamer Coskun, Malgorzata D Gonciarz, et al.
Acta Physiologica (Oxford, England)|February 24, 2015
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cellsL Jean-Gilles, M Braitch, M L Latif, et al.
Andrology|March 13, 2018
Development of a selective androgen receptor modulator for transdermal use in hypogonadal patientsV Krishnan, N J Patel, J G Mackrell, et al.
Pageof 23